Hmgb1-TLR4-IL-23-IL-17A axis promote ischemia-reperfusion injury in a cardiac transplantation model

Transplantation

Volumn 95, Issue 12, 2013, Pages 1448-1454

  Zhu, Hongfei ^a   Li, Jun ^b   Wang, Sihua ^c   Liu, Kebin ^a   Wang, Li ^a   Huang, Lili ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN CENTRAL HOSPITAL   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

High mobility group box 1; IL 17A; IL 23; Ischemia reperfusion injury; TLR4

Indexed keywords

GADOLINIUM; GADOLINIUM TRICHLORIDE; GAMMA DELTA T LYMPHOCYTE RECEPTOR MONOCLONAL ANTIBODY; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 23; INTERLEUKIN 23 ANTIBODY; INTERLEUKIN 23P19 ANTIBODY; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GAMMA DELTA T LYMPHOCYTE; GRAFT RECIPIENT; HEART TRANSPLANTATION; ISOGRAFT; LYMPHOCYTIC INFILTRATION; MALE; MOLECULAR PATHOLOGY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REPERFUSION INJURY;

ANIMALS; APOPTOSIS; CELL SEPARATION; CYTOKINES; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HEART FAILURE; HEART TRANSPLANTATION; HMGB1 PROTEIN; INTERLEUKIN-17; INTERLEUKIN-23; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; MYOCYTES, CARDIAC; NEUTROPHILS; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 4;

EID: 84880132829     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318293b7e1     Document Type: Article

References (39)

1. Wiedemann D, Schneeberger S, Friedl P, et al. The fibrin-derived peptide Bbeta(15Y42) significantly attenuates ischemia-reperfusion injury in a cardiac transplant model. Transplantation 2010; 89: 824.
2. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity 2004; 21: 467.
3. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005; 6: 1123.
4. Cua DJ, Tato CM. Innate IL-17-producing cells: the sentinels of the immune system. Nat Rev Immunol 2010; 10: 479.
5. Ley K, Smith E, Stark MA. IL-17A-producing neutrophil-regulatory Tn lymphocytes. Immunol Res 2006; 34: 229.
6. Liao YH, Xia N, Zhou SF, et al. Interleukin-17A contributes to myo-cardial ischemia/reperfusion injury by regulating cardiomyocyte ap-optosis and neutrophil infiltration. J Am Coll Cardiol 2012; 59: 420.
7. Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 2009; 15: 946.
8. Li L, Huang L, Vergis AL, et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010; 120: 331.
9. + T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice. Clin Immunol 2009; 130: 313.
10. Sims GP, Rowe DC, Rietdijk ST, et al. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol 2010; 28: 367.
11. Tang D, Kang R, Zeh HR, et al. High-mobility group box 1 and cancer. Biochim Biophys Acta 2010; 1799: 131.
12. Yan W, Chang Y, Liang X, et al. High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology 2012; 55: 1863.
13. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2: 675.
14. Baumgarten G, Knuefermann P, Nozaki N, et al. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of Toll-like receptor-4. J Infect Dis 2001; 183: 1617.
15. Cha J, Wang Z, Ao L, et al. Cytokines link Toll-like receptor 4 signaling to cardiac dysfunction after global myocardial ischemia. Ann Thorac Surg 2008; 85: 1678.
16. Hamacher-Brady A, Brady NR, Gottlieb RA. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther 2006; 20: 445.
17. Chandrasekar B, Colston JT, de la Rosa SD, et al. TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation. Biochem Biophys Res Commun 2003; 303: 1152.
18. Onishi RM, Gaffen SL. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 2010; 129:311.
19. Steffens S, Montecucco F, Mach F. The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. Thromb Haemost 2009; 102: 240.
20. Linfert D, Chowdhry T, Rabb H. Lymphocytes and ischemia-reperfusion injury. Transplant Rev (Orlando) 2009; 23: 1.
21. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 2006; 6: 329.
22. + T cells. J Exp Med 2008; 205: 1019.
23. Nakamura M, Wang NP, Zhao ZQ, et al. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 2000; 45: 661.
24. Bettelli E, Korn T, Oukka M, et al. Induction and effector functions of T(H)17 cells. Nature 2008; 453: 1051.
25. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost 2007; 97: 738.
26. Ruddy MJ, Shen F, Smith JB, et al. Interleukin-17 regulates expression of the CXC chemokine LIX/CXCL5 in osteoblasts: implications for inflammation and neutrophil recruitment. J Leukoc Biol 2004; 76: 135.
27. Sun J, Walsh M, Villarino AV, et al. TLR ligands can activate dendritic cells to provide a MyD88-dependent negative signal for Th2 cell development. J Immunol 2005; 174: 742.
28. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233.
29. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8: 958.
30. Wang X, Sun R, Wei H, et al. High-mobility group box 1 (HMGB1)-Toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: Interaction of gammadelta T cells with macrophages. Hepatology 2013; 57: 373.
31. Dumitriu IE, Baruah P, Manfredi AA, et al. HMGB1: guiding immunity from within. Trends Immunol 2005; 26: 381.
32. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191.
33. Zeuke S, Ulmer AJ, Kusumoto S, et al. TLR4-mediated inflammatory activation of human coronary artery endothelial cells by LPS. Cardiovasc Res 2002; 56: 126.
34. Altavilla D, Deodato B, Campo GM, et al. IRFI 042, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor-kappaB and reduces the inflammatory response in myocardial ischemia-reperfusion injury. Cardiovasc Res 2000; 47: 515.
35. Shimamoto A, Chong AJ, Yada M, et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006; 114: I270.
36. Kleinschek MA, Muller U, Brodie SJ, et al. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol 2006; 176: 1098.
37. Li J, Chen G, Ye P, et al. CCR5 blockade in combination with cyclo-sporine increased cardiac graft survival and generated alternatively activated macrophages in primates. J Immunol 2011; 186: 3753.
38. Gorbacheva V, Fan R, Li X, et al. Interleukin-17 promotes early allo-graft inflammation. Am J Pathol 2010; 177: 1265.
39. Xie JJ, Wang J, Tang TT, et al. The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine 2010; 49: 185.